Federal Register / Vol. 65, No. 12 / Wednesday, January 19, 2000 / Notices 2973

The meetings will be closed to the

public in accordance with the

provisions set forth in section 552b(c)(4)

and 552b(c)(6), Title 5 U.S.C., as

amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Diabetes and

Digestive and Kidney Diseases Advisory

Council.

Date: February 2–3, 2000.

Open: February 2, 2000, 8:30 a.m. to 12

p.m.

Agenda: Grant applications.

Place: National Institutes of Health,

Building 31, Conference Room 10, Bethesda,

MD 20892.

Closed: February 3, 2000, 8:30 a.m. to 9

a.m.

Agenda: To review and evaluate grant

applications.

Place: National Institutes of Health,

Building 31, Conference Room 10, Bethesda,

MD 20892.

Open: February 3, 2000, 9 a.m. to 12 p.m.

Agenda: Grant applications.

Place: National Institutes of Health,

Building 31, Conference Room 10, Bethesda,

MD 20892.

Contact Person: Walter S. Stolz, PhD.,

Director for Extramural Activities, National

Institutes of Diabetes and Digestive and

Kidney Diseases, National Institutes of

Health, PHS, DHHS, Bethesda, MD 20892.

Name of Committee: National Diabetes and

Digestive and Kidney Diseases Advisory

Council Kidney, Urologic and Hematologic

Diseases Subcommittee..

Date: February 2, 2000.

Open: 1:30 p.m. to 2:30 p.m.

Agenda: Grant applications.

Place: National Institutes of Health, 9000

Rockville Pike, Building 31, Conference

Room 7.

Closed: 2:30 p.m. to 5:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: National Institutes of Health, 9000

Rockville Pike, Building 31, Conference

Room 7.

Contact Person: Walter S. Stolz, PhD.,

Director for Extramural Activities, National

Institutes of Diabetes and Digestive and

Kidney Diseases, National Institutes of

Health, PHS, DHHS, Bethesda, MD 20892.

Name of Committee: National Diabetes and

Digestive and Kidney Diseases Advisory

Council Diabetes, Endocrine and Metabolic

Diseases Subcommittee.

Date: February 2, 2000.

Open: 1:30 p.m. to 2:30 p.m.

Agenda: Grant applications.

Place: National Institutes of Health,

Building 31, Conference Room 10, Bethesda,

MD 20892.

Closed: 2:30 p.m. to 5:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: National Institutes of Health,

Building 31, Conference Room 10, Bethesda,

MD 20892.

Contact Person: Walter S. Stolz, PhD.,

Director for Extramural Activities, National

Institutes of Diabetes and Digestive and

Kidney Diseases, National Institutes of

Health, PHS, DHHS, Bethesda, MD 20892.

Name of Committee: National Diabetes and

Digestive and Kidney Diseases Advisory

Council Digestive Diseases and Nutrition

Subcommittee.

Date: February 2, 2000.

Open: 1:30 p.m. to 2:30 p.m.

Agenda: Grant applications.

Place: National Institutes of Health, 9000

Rockville Pike, Building 31, Conference

Room 9A51.

Closed: 2:30 p.m. to 5:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: National Institutes of Health, 9000

Rockville Pike, Building 31, Conference

9A51.

Contact Person: Walter S. Stolz, PhD.,

Director for Extramural Activities, National

Institutes of Diabetes and Digestive and

Kidney Diseases, National Institutes of

Health, PHS, DHHS, Bethesda, MD 20892.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.847, Diabetes,

Endocrinology and Metabolic Research;

93.848, Digestive Diseases and Nutrition

Research; 93.849, Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health, HHS).

Dated: January 11, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–1141 Filed 1–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposal and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel

‘‘Telemedicin’’.

Date: January 18, 2000.

Time: 9 a.m. to 5 p.m.

Agenda: To review and evaluate contract

proposals.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892.

Contact Person: Richard C. Harrison, Chief,

Contract Review Branch, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, 301–435–1437.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health,

HHS).

Dated: January 11, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–1142 Filed 1–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Mental Health;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: January 14, 2000.

Time: 12 pm to 1 pm.

Agenda: To review and evaluate grant

applications.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20982, (telephone Conference

Call).